Impairments in neurogenesis are not tightly linked to depressive behavior in a transgenic mouse model of Alzheimer's disease

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Iascone, Daniel M ^a   Padidam, Sneha ^a   Pyfer, Mark S ^a   Zhang, Xiaohong ^a   Zhao, Lijuan ^a   Chin, Jeannie ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; DEPRESSION; DISEASE MODEL; FEMALE; GENETICS; GENOTYPE; HIPPOCAMPUS; HUMAN; MALE; MEMORY; METABOLISM; MOUSE; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; PHENOTYPE; PSYCHOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; MALE; MEMORY; MICE; MICE, TRANSGENIC; NEUROGENESIS; PHENOTYPE;

EID: 84893645323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079651     Document Type: Article

References (37)

1. Holtzman DM, Morris JC, Goate AM (2011) Alzheimer's disease: the challenge of the second century. Sci Transl Med 3: 77sr71.
2. Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: back to the future. Neuron 68: 270-281.
3. Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid beta-protein: Synaptic and network dysfunction. Cold Spring Harb Perspect Med 2: a006338.
4. Selkoe DJ (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192: 106-113.
5. Jin KL, Galvan V, Xie L, Mao XO, Gorostiza OF, et al. (2004) Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPsw,lnd)mice. Proc Natl Acad Sci USA 101: 13363-13367. (Pubitemid 39209671)
6. Lopez-Toledano MA, Shelanski ML (2007) Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). J Alzheimers Dis 12: 229-240. (Pubitemid 350179250)
7. Rodriguez JJ, Verkhratsky A (2011) Neurogenesis in Alzheimer's disease. J Anat 219: 78-89.
8. Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol Neurodegener 6: 85 (81-89).
9. Ming GL, Song H (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70: 687-702.
10. Deng W, Aimone JB, Gage FH (2010) New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 11: 339-350.
11. Fuentealba LC, Obernier K, Alvarez-Buylla A (2012) Adult neural stem cells bridge their niche. Cell Stem Cell 10: 698-708.
12. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368: 387-403. (Pubitemid 44108123)
13. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA (2011) A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 12: 585-601.
14. Winner B, Kohl Z, Gage FH (2011) Neurodegenerative disease and adult neurogenesis. Eur J Neurosci 33: 1139-1151.
15. Thompson A, Boekhoorn K, Van Dam AM, Lucassen PJ (2008) Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence? Genes Brain Behav 7 Suppl 1: 28-42.
16. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809. (Pubitemid 36962615)
17. David DJ, Wang J, Samuels BA, Rainer Q, David I, et al. (2010) Implications of the functional integration of adult-born hippocampal neurons in anxietydepression disorders. Neuroscientist 16: 578-591.
18. Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, et al. (2005) Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115: 3104-3116. (Pubitemid 41567575)
19. Eisch AJ, Petrik D (2012) Depression and hippocampal neurogenesis: a road to remission? Science 338: 72-75.
20. Encinas JM, Enikolopov G (2008) Identifying and quantitating neural stem and progenitor cells in the adult brain. Methods Cell Biol 85: 243-272.
21. Encinas JM, Michurina TV, Peunova N, Park JH, Tordo J, et al. (2011) Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus. Cell Stem Cell 8: 566-579.
22. Porsolt RD, Brossard G, Hautbois C, Roux S (2001) Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci Chapter 8: Unit 8 10A.
23. Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, et al. (2003) Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci USA 100: 9572-9577. (Pubitemid 37033969)
24. Chin J, Palop JJ, Puolivali J, Massaro C, Bien-Ly N, et al. (2005) Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci 25: 9694-9703. (Pubitemid 41510910)
25. Chin J (2011) Selecting a mouse model of Alzheimer's disease. Methods Mol Biol 670: 169-189.
26. Hall AM, Roberson ED (2012) Mouse models of Alzheimer's disease. Brain Res Bull 88: 3-12.
27. Sun B, Halabisky B, Zhou Y, Palop JJ, Yu G, et al. (2009) Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease. Cell Stem Cell 5: 624-633.
28. Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9: 326-357. (Pubitemid 38534696)
29. Saura CA, Chen G, Malkani S, Choi SY, Takahashi RH, et al. (2005) Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J Neurosci 25: 6755-6764. (Pubitemid 41023143)
30. Cheng I, Scearce-Levie K, Legleiter J, Palop J, Gerstein H, et al. (2007) Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 282: 23818-23828. (Pubitemid 47328006)
31. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, et al. (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316: 750-754. (Pubitemid 46717684)
32. Cisse M, Halabisky B, Harris J, Devidze N, Dubal DB, et al. (2011) Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469: 47-52.
33. Lyketsos CG, Olin J (2002) Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry 52: 243-252. (Pubitemid 35232091)
34. Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, et al. (2009) Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 5: 245-255.
35. Filali M, Lalonde R, Rivest S (2009) Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav 8: 143-148.
36. Becker C, Zeau B, Rivat C, Blugeot A, Hamon M, et al. (2008) Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol Psychiatry 13: 1079-1092.
37. Tarawneh R, Holtzman DM (2012) The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med 2: a006148.